Loading...
skip to Main Content

#LiverTwitter, I’m delighted to be sharing good news! 📢 My abstract has been accepted 🏆 for the #EASL #NAFLDsummit 2022.

I’m looking forward to sharing my research 🧪🔬🩺 & connecting with the #hepatology community!

Join me ➡️ Register now! https://bit.ly/3PtXzn0

#LiverTwitter, I’m delighted to be sharing good news! 📢 My abstract has been accepted 🏆 for the #EASL #NAFLDsummit 2022.

I’m looking forward to sharing my research 🧪🔬🩺 & connecting with the #hepatology community!

Join me ➡️ Register now! https://bit.ly/3PtXzn0

Do you know where the scientific community interested in #NAFLD and #NASH will be in September?

🎯At the EASL #NAFLDSummit 2022, 15-17 September, Dublin & online!

Discover the 3 day scientific programme of the leading event of the year
👉https://easl.eu/Nafld_22prog

#LiverTwitter

ligneverte

Discover the Scientific Programme

Explore the three summit days and ten scientific programme sessions reflecting on the current status of clinical trials, the knowledge and trends in the treatment of NAFLD and what the future of research and treatment of NAFLD will be.

NAFLD-2022-programme-overview
View the full programme

Session 1: Epidemiology, disease modifiers, and models of care

  • Current epidemiology and future trends
  • Nutrition, alcohol, and environmental toxins as (co-) factors of NAFLD
  • Case finding, screening of risk populations, and clinical algorithms
  • Evolving models of care: How will the future look?
  • Panel discussion

Session 2: New technologies for better stratification of patients

  • Disease phenotyping by metabolomics and lipidomics
  • Are polygenic risk scores ready for clinical routine?
  • Machine learning approaches relating to NAFLD
  • Digital pathology and image analysis
  • Panel discussion

Session 3: Non-invasive fibrosis markers : Present and future

  • Serum-based biomarkers: Staging and treatment response
  • Imaging biomarkers: Staging and treatment response
  • Panel discussion: The future of liver biopsy

Session 4: Mechanisms of disease progression and implications for therapeutic targets

  • Advances in understanding intrinsic mechanisms in NAFLD: metabolism
  • Advances in understanding intrinsic mechanisms in NAFLD: inflammation, fibrosis
  • Organ cross-talk as a NAFLD modulator: gut and adipose tissue
  • Organ cross-talk as a NAFLD modulator: brain and endocrine signals
  • Panel discussion

Session 5: New approaches to lifestyle modification – case-based discussion

  • Case presentation
  • Short presentations from different disciplines:
    - Nutrition & app specialist
    - Exercise trainer
    - Bariatric surgeon
    - Hepatology
  • Panel discussion

Session 6: Personalized medicine in 2032 – how will it look like?

  • Sexual dimorphism: the overlooked obvious?
  • Gut microbiota as a target for personalized NAFLD interventions
  • Gene silencing by siRNA treatment
  • Biomarkers for personalized NAFLD medicine – thinking outside the box
  • Panel discussion

Session 7: Overlooked issues in clinical trials

  • Cardiovascular safety
  • Extrahepatic malignancies
  • Alcohol misuse, depression, anxiety
  • The patient’s perspective
  • Panel discussion

Session 8: How do pharmacological treatments of comorbidities affect NAFLD – case-based discussion

  • Case presentation
  • Short presentations from different disciplines:
    - Obesity
    - Dyslipidemia
    - Diabetes
    - Hypothyreoidism
  • Panel discussion

Session 9: Why do trials fail? Industry perspective & academia perspective 

  • Selonsertib
  • Cenicriviroc
  • Elafibranor
  • Panel discussion: Consequences for future trials?

Session 10: Clinical trial landscape in 2022

  • Phase 1-2 drug candidates for non-cirrhotic NASH
  • Phase 3 non-cirrhotic NASH
  • Cirrhotic NASH
  • Discussion

#LiverTwitter, I’m delighted to be sharing good news! 📢 My abstract has been accepted 🏆 for the #EASL #NAFLDsummit 2022.

I’m looking forward to sharing my research 🧪🔬🩺 & connecting with the #hepatology community!

Join me ➡️ Register now! https://bit.ly/3PtXzn0

#LiverTwitter, I’m delighted to be sharing good news! 📢 My abstract has been accepted 🏆 for the #EASL #NAFLDsummit 2022.

I’m looking forward to sharing my research 🧪🔬🩺 & connecting with the #hepatology community!

Join me ➡️ Register now! https://bit.ly/3PtXzn0

Do you know where the scientific community interested in #NAFLD and #NASH will be in September?

🎯At the EASL #NAFLDSummit 2022, 15-17 September, Dublin & online!

Discover the 3 day scientific programme of the leading event of the year
👉https://easl.eu/Nafld_22prog

#LiverTwitter

Back To Top